Atrial fibrillation with RVR: Difference between revisions
VadimKeyfes (talk | contribs) (reference) |
VadimKeyfes (talk | contribs) (updated reference) |
||
| Line 95: | Line 95: | ||
== Source == | == Source == | ||
<references/> | <references/> | ||
[[Category:Cards]] | [[Category:Cards]] | ||
Revision as of 01:15, 21 October 2014
Unstable
- Synchronized cardioversion (100-200J)
- Indications: ischemic CP, SBP < 90, acute pulmonary edema, AMS
- If shock doesn't work:
- Verify not preexcitation
- Incr diastolic BP to perfuse the heart
- Push-dose phenyleprhine
- Will maintain BP when give rate-control meds
- 50-200mcg q2-5min w/ goal DBP >60
- Push-dose phenyleprhine
- Amiodarone 150mg over 10min OR diltiazem 2.5mg/min until HR<100 or max 50mg
- Anticoagulate before cardioversion if time permits, otherwise immediately after cardioversion. (unless you are sure it has been <48 hours since onset of afib) [1]
Stable
- Goal <120bpm
- Make sure you not slowing down a normal physiologic response (e.g. fever, hypoxia, etc)
Cardioversion
- Consider for:
- Symptoms <48hr
- New diagnosis
- No history of similar episodes
- No LV dysfunction
- No mitral valve disease
- No prior thromboembolic event
- Already Anticoagulated
Calcium-Channel Blockers
Contraindications:
- Decompensated heart failure
- Preexcitation (especially in pediatrics)
- Significant hypotension
Diltiazem
- Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
- If, after 15min 1st dose is tolerated but inadequate re-bolus 0.35 mg/kg
- If patient responds start infusion at 5-15mg/hr or give PO dilt 30mg QID
Beta-Blockers
- Particularly useful when A-fib a/w exercise, after acute MI, or w/ thyrotoxicosis
- Also long-term beta blocker improves patient survival whereas non-dihydropyridine calcium channel blockers may even worsen outcomes. Important to consider if a patient will most likely be started on a beta blocker upon discharge then strongly consider using the agent for acute conversion if they do not have any relative contraindications.[3][4]
Contraindications:
- COPD
- Asthma
- Decompensated heart failure
- Hypotension
Metoprolol
- Bolus 2.5-5mg IVP over 2min q5min up to 3 doses
- If patient responds orally load with 25-50mg
Esmolol
- Use if unsure whether patient will tolerate a beta blocker since the duration of action is only 10 minutes
- Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
- If, after 4min response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
- If, after 4min response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
- If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
Digoxin
- Consider as initial therapy for pts with LV dysfunction who:
- Do not achieve rate control targets on beta blockers alone
- Cannot tolerate addition of or increased doses of beta blocker due to decompensated CHF
- Would have digoxin added anyway to improve CHF symptoms independent of A-fib
- Consider as initial therapy in pts with severe hypotension
- Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
- May take up to 6-8 hours to work
- Dosing
- 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
- Adjust dose in presence of renal failure, amiodarone, etc
Amiodarone
- Consider for pts with decompensated heart failure or those with accessory pathways
- 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
- Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24hr via continuous infusion or in divided oral doses
Stable and Asymptomatic
If mild or no symptoms and pulse only mildly elevated (<120bpm) ok to manage with PO meds
Evidence of preexcitation
- Avoid AV nodal agents
- Unstable:
- Unsynchronized cardioversion (200J)
- Procainamide (if cardioversion unsuccessful)
- 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
- Stable:
- Try to avoid cardioversion without adequate anticoagulation
See Also
External Links
Source
- ↑ You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e531S-75S
- ↑ Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011 May 10;342:d2549
- ↑ Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999 Jun 12;353(9169):2001-7
- ↑ Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II–DAVIT II). Am J Cardiol. 1990 Oct 1;66(10):779-85
